Zobrazeno 1 - 10 of 130 pro vyhledávání: '"SD Rowley"'
1
Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation
Autor: SD Rowley, WI Bensinger, TA Gooley, CD Buckner
Publikováno v: Blood. 83(9)
The effects of cell concentration during cryopreservation on bone marrow (BM) or peripheral blood (PB)-derived hematopoietic progenitor cells have not been described. The much greater numbers of cells harvested for autologous PB stem cell (PBSC) tran
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0677181de1ac34f9be9bd2e95b0aaf6
https://pubmed.ncbi.nlm.nih.gov/7513212
Zobrazit plný text záznamu
2
Clinical toxicity of cryopreserved bone marrow graft infusion
Autor: JM Davis, SD Rowley, HG Braine, S Piantadosi, GW Santos
Publikováno v: Blood. 75(3)
We prospectively evaluated infusion-related toxicities in 82 recipients of autologous bone marrow grafts. The grafts were cryopreserved in 10% dimethylsulfoxide and stored in liquid nitrogen. All grafts were concentrated and buffy-coat cells were col
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72dd65cf1de20c8e7b0d14bf9502c8f
https://pubmed.ncbi.nlm.nih.gov/2297578
Zobrazit plný text záznamu
3
Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia
Autor: SD Rowley, RJ Jones, S Piantadosi, HG Braine, OM Colvin, J Davis, R Saral, S Sharkis, J Wingard, AM Yeager
Publikováno v: Blood. 74:501-506
We used an in vitro measure of drug activity to predict the efficacy of ex vivo purging of leukemic cells from autologous bone marrow grafts. We previously found that the myeloid progenitor cell (CFU-GM) content of the marrow grafts after ex vivo pur
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a7588d094740f002b7587701afa91fe1
https://doi.org/10.1182/blood.v74.1.501.501
Zobrazit plný text záznamu
4
CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow
Autor: SD Rowley, M Zuehlsdorf, HG Braine, OM Colvin, J Davis, RJ Jones, R Saral, LL Sensenbrenner, A Yeager, GW Santos
Publikováno v: Blood. 70(1)
Autologous bone marrow transplants (BMTs) can repopulate the hematologic system of patients treated with marrow-ablative chemotherapy and/or radiotherapy. However, treatment of the bone marrow graft to eliminate residual tumor cells prior to reinfusi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d45272a6e0ab2496d6fe5bef25c5b57b
https://pubmed.ncbi.nlm.nih.gov/3297203
Zobrazit plný text záznamu
5
Progenitor cell assays predict hematopoietic reconstitution after syngeneic transplantation in mice
Autor: RJ Jones, SJ Sharkis, P Celano, OM Colvin, SD Rowley, LL Sensenbrenner
Publikováno v: Blood. 70(4)
Hematopoietic reconstitution following syngeneic bone marrow transplantation with graded doses of untreated and drug-treated bone marrow was studied in B6D2F1 mice. Granulocyte-macrophage colony- forming units (CFU-GM) and spleen colony-forming units
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807402c847f5658d706042db6b56f3d5
https://pubmed.ncbi.nlm.nih.gov/3307950
Zobrazit plný text záznamu
6
Akademický článek
Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Autor: Gyurkocza B; David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY., Nath R; Banner MD Anderson Cancer Center, Gilbert, AZ., Seropian S; Yale University School of Medicine-Yale Cancer Center, New Haven, CT., Choe H; The Ohio State University, Columbus, OH., Litzow MR; Mayo Clinic, Rochester, MN., Abboud C; Washington University School of Medicine, St Louis, MO., Koshy N; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX., Stiff P; Loyola University Medical Center, Maywood, IL., Tomlinson B; University Hospitals Cleveland Medical Center, Cleveland, OH., Abhyankar S; University of Kansas Cancer Center, Kansas City, KS., Foran J; Mayo Clinic, Jacksonville, FL., Hari P; Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, WI., Chen G; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; MD Anderson Cancer Center, Houston, TX., Al-Kadhimi Z; University of Nebraska Medical Center, Omaha, NE., Kebriaei P; MD Anderson Cancer Center, Houston, TX., Sabloff M; University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Orozco JJ; Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA., Jamieson K; University of North Carolina (UNC), Chapel Hill, NC., Silverman M; University of Iowa, Iowa City, IA., Van Besien K; Weill Cornell Medical College, New York, NY., Schuster M; Stony Brook University Cancer Center, Stony Brook, NY., Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada., Larkin K; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH., Pandit-Taskar N; Department of Radiology, Memorial Sloan Kettering, New York, NY., Rowley SD; Hackensack University Medical Center, Hackensack, NJ., Munshi P; MedStar Georgetown University Hospital, Washington, DC., Cook R; Oregon Health & Science University, Portland, OR., Levy MY; Baylor Scott & White Health, Dallas, TX., Lazarus HM; Case Western Reserve University, Cleveland, OH., Sandmaier BM; Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA., Pagel JM; Loxo Oncology at Lilly, Stamford, CT., Reddy V; D2V Clinical, Raleigh, Durham, NC., MacDougall J; Statistical Consultant to Actinium Pharmaceuticals, New York, NY., McNamara K; Actinium Pharmaceuticals, New York, NY., Spross J; Actinium Pharmaceuticals, New York, NY., Haeuber E; Actinium Pharmaceuticals, New York, NY., Vusirikala M; Actinium Pharmaceuticals, New York, NY., Nahar A; Actinium Pharmaceuticals, New York, NY., Desai A; Actinium Pharmaceuticals, New York, NY., Giralt S; David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 19, pp. JCO2302018. Date of Electronic Publication: 2024 Sep 19.
Zobrazit plný text záznamu
7
Akademický článek
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.
Autor: Eapen M; Division of Haematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Antin JH; Dana-Farber Cancer Institute, Boston, MA, USA., Tolar J; Pediatric Blood and Marrow Transplant Program, University of Minnesota, MN, USA., Arai S; Stanford Hospital and Clinics, Stanford, CA, USA., Horwitz ME; Duke University School of Medicine, Durham, NC, USA., Kou J; National Marrow Donor Program, Minneapolis, MN, USA., Leifer E; Intramural Research, National Heart Lung and Blood Institute, Bethesda, MD, USA., McCarty JM; Virginia Commonwealth University, Richmond, VA, USA., Nakamura R; City of Hope National Medical Centre, Durate, CA, USA., Pulsipher MA; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Rowley SD; Hackensack University Medical Centre, Hackensack, NJ, USA., Horowitz MM; Centre for International Blood and Marrow Transplant Program, Medical College of Wisconsin, WI, USA., Deeg HJ; Fred Hutchinson Cancer Centre, Seattle, WA, USA.
Publikováno v: EClinicalMedicine [EClinicalMedicine] 2024 Sep 05; Vol. 76, pp. 102819. Date of Electronic Publication: 2024 Sep 05 (Print Publication: 2024).
Zobrazit plný text záznamu
8
Akademický článek
Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapy.
Autor: Danish A; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States.; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, United States., Della Pia A; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States., Fogel L; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, United States., Alkhatatneh H; Department of Medicine, Englewood Hospital and Medical Center, Englewood, NJ, United States., Zhao C; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, United States., Varughese T; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, United States., Al Feghali KA; RefleXion Medical, Inc., Hayward, CA, United States., Pascual L; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States., Sinclaire B; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States., Marafelias M; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States., Zenreich J; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States., Kuo YH; Office of Research Administration, Hackensack Meridian Health Research Institute, Nutley, NJ, United States., Feldman TA; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States.; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, United States.; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, United States., Zhang Y; Center for Discovery and Innovation, Hackensack Meridian Health, Hackensack, NJ, United States., Goy AH; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States.; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, United States.; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, United States., Ip A; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States.; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, United States.; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, United States., Rowley SD; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, United States.; Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, United States.; Department of Oncology, Georgetown University School of Medicine, Washington, DC, United States.
Publikováno v: Frontiers in oncology [Front Oncol] 2024 Aug 19; Vol. 14, pp. 1425506. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Akademický článek
Greater Social Isolation and Social Constraints Prior to Hematopoietic Stem Cell Transplant Are Associated with Greater Anxiety and Depressive Symptoms.
Autor: Shahrour L; Georgetown University, Washington, D.C, USA., Martinez J; Cornell University, Ithaca, NY, USA., Chicaiza A; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA., Omar R; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Bovbjerg K; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Stanton AL; Department of Psychology, University of California, Los Angeles, CA, USA., Valdimarsdottir H; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Psychology, Reykjavik University, Reykjavik, Iceland., Yanez B; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Munshi P; MedStar Georgetown University Hospital, Washington, D.C, USA., Rowley SD; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, USA., Rini C; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Graves KD; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA. Kristi.Graves@georgetown.edu.
Publikováno v: International journal of behavioral medicine [Int J Behav Med] 2024 Jun; Vol. 31 (3), pp. 341-351. Date of Electronic Publication: 2023 Nov 28.
Zobrazit plný text záznamu
10
Akademický článek
Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation.
Autor: Rowley SD; Georgetown University School of Medicine, Washington, DC 20007, USA.; John Theurer Cancer Center, Hackensack, NJ 07601, USA., Gunning TS; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Pelliccia M; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Della Pia A; John Theurer Cancer Center, Hackensack, NJ 07601, USA., Lee A; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Behrmann J; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Bangolo A; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Jandir P; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Zhang H; Genomic Testing Cooperative, Irvine, CA 92618, USA., Kaur S; John Theurer Cancer Center, Hackensack, NJ 07601, USA.; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Suh HC; John Theurer Cancer Center, Hackensack, NJ 07601, USA.; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Donato M; John Theurer Cancer Center, Hackensack, NJ 07601, USA.; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA., Albitar M; Genomic Testing Cooperative, Irvine, CA 92618, USA., Ip A; John Theurer Cancer Center, Hackensack, NJ 07601, USA.; Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA.
Publikováno v: Cancers [Cancers (Basel)] 2024 Mar 29; Vol. 16 (7). Date of Electronic Publication: 2024 Mar 29.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje